EB
Eastern Bank Portfolio holdings
AUM
$5.25B
1-Year Return
18.41%
This Quarter Return
+8.27%
1 Year Return
+18.41%
3 Year Return
+75.93%
5 Year Return
+122.48%
10 Year Return
+263.99%
AUM
$2.04B
AUM Growth
+$189M
(+10%)
Cap. Flow
+$60.1M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
28.22%
Holding
190
New
7
Increased
92
Reduced
49
Closed
3
Top Buys
| 1 |
Moderna
MRNA
|
$23.7M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$23M |
| 3 |
Nuveen ESG Small-Cap ETF
NUSC
|
$5.12M |
| 4 |
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
|
$2.82M |
| 5 |
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
|
$2.03M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$23.7M |
| 2 |
Merck
MRK
|
$693K |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$466K |
| 4 |
iShares Russell 1000 ETF
IWB
|
$445K |
| 5 |
Verizon
VZ
|
$353K |
Sector Composition
| 1 | Technology | 16.45% |
| 2 | Financials | 10.49% |
| 3 | Healthcare | 10.3% |
| 4 | Consumer Discretionary | 7.73% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Brown-Forman Class A
BF.A
$13.5B
| $531K | 0.03% |
7,530
| – | – |
|
152
Berkshire Hathaway Class B
BRK.B
$1.09T
| $530K | 0.03% |
1,907
-20
| -1% | -$5.56K |
|
153
Morgan Stanley
MS
$240B
| $492K | 0.02% |
5,351
-231
| -4% | -$21.2K |
|
154
Starbucks
SBUX
$98.9B
| $471K | 0.02% |
4,215
-58
| -1% | -$6.48K |
|
155
iShares Core S&P 500 ETF
IVV
$666B
| $430K | 0.02% |
1,000
| – | – |
|
156
Invesco WilderHill Clean Energy ETF
PBW
$348M
| $423K | 0.02% |
4,537
+1,385
| +44% | +$129K |
|
157
Becton Dickinson
BDX
$54.8B
| $422K | 0.02% |
1,780
-191
| -10% | -$45.3K |
|
158
Ford
F
$46.5B
| $410K | 0.02% |
+27,551
| New | +$410K |
|
159
Bristol-Myers Squibb
BMY
$95B
| $405K | 0.02% |
6,049
| – | – |
|
160
IBM
IBM
$230B
| $405K | 0.02% |
2,886
-444
| -13% | -$62.3K |
|
161
Vanguard Total Stock Market ETF
VTI
$529B
| $398K | 0.02% |
1,783
| – | – |
|
162
VF Corp
VFC
$5.85B
| $392K | 0.02% |
4,795
| – | – |
|
163
iShares S&P 500 Growth ETF
IVW
$63.7B
| $382K | 0.02% |
5,250
-130
| -2% | -$9.46K |
|
164
Goldman Sachs
GS
$227B
| $380K | 0.02% |
1,000
| – | – |
|
165
Oracle
ORCL
$626B
| $362K | 0.02% |
4,643
-176
| -4% | -$13.7K |
|
166
Polaris
PII
$3.26B
| $356K | 0.02% |
2,600
| – | – |
|
167
Monster Beverage
MNST
$62B
| $334K | 0.02% |
7,306
| – | – |
|
168
iShares Morningstar Growth ETF
ILCG
$2.94B
| $324K | 0.02% |
5,000
| – | – |
|
169
Organon & Co
OGN
$2.52B
| $319K | 0.02% |
+10,568
| New | +$319K |
|
170
iShares Russell Mid-Cap ETF
IWR
$44.5B
| $308K | 0.02% |
3,886
+870
| +29% | +$69K |
|
171
iShares Russell 1000 Growth ETF
IWF
$118B
| $304K | 0.01% |
1,119
| – | – |
|
172
BP
BP
$88.4B
| $292K | 0.01% |
11,058
-204
| -2% | -$5.39K |
|
173
Biogen
BIIB
$20.5B
| $291K | 0.01% |
840
| – | – |
|
174
Charles Schwab
SCHW
$177B
| $283K | 0.01% |
3,892
-431
| -10% | -$31.3K |
|
175
Dominion Energy
D
$50.2B
| $276K | 0.01% |
3,755
-184
| -5% | -$13.5K |
|